Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 714843Generated: October 30, 2026

Cesium carbonate → (3S)-3-cyclopropyl-1-(2-((1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-oxopyrrolidine-3-carbonitrile

https://huagongshe.com/reaction/714843

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCesium carbonateHCID 10796—
ReactantSodium BicarbonateHCID 516892—
ReactantBinap, (A+-)-HCID 634876—
Reactant(1-(4-amino-1H-pyrazol-1-yl)cyclopropyl)methanolHCID 91618623—
Reactant(3S)-1-(2-chloropyrimidin-4-yl)-3-cyclopropyl-2-oxopyrrolidine-3-carbonitrileHCID 117840203—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
SolventTetrahydrofuranHCID 8028—
SolventAcetonitrile--water (1/1)HCID 18373917—
Product(3S)-3-cyclopropyl-1-(2-((1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-oxopyrrolidine-3-carbonitrileHCID 7176689424.6%

Reaction Conditions

Temperature90 °C

Reaction Steps

To a solution of (3S)-1-(2-chloropyrimidin-4-yl)-3-cyclopropyl-2-oxopyrrolidine-3-carbonitrile (200 mg) obtained in Step E of Example 103, (1-(4-amino-1H-pyrazol-1-yl)cyclopropyl)methanol (120 mg) obtained in Step C of Example 128, cesium carbonate (500 mg) and 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (71 mg) in tetrahydrofuran (10 mL) was added tris(dibenzylideneacetone)dipalladium(0) (70 mg), and the mixture was stirred at 90° C. for 10 hr under argon atmosphere. The solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (NH, hexane/ethyl acetate). The obtained crude product was subjected to HPLC (C18, mobile phase: water/acetonitrile (containing 5 mM AcONH4), to the obtained fraction was added saturated aqueous sodium hydrogen carbonate solution, and the mixture was extracted with ethyl acetate. The extract was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was recrystallized (ethyl acetate/diisopropyl ether) to give the title compound (71 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09187453B2
Source datasetuspto-grants-2015_11
ORD IDord-3bae1e8940e84fa2856d2f03a3f3b19b
Source noteuspto-grants-2015_11